Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

<< < Results 11 - 20 of 33 > >>
EC Number Protein Variants Commentary Reference
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4more development of a synthetic 3-ketosteroid DELTA1-dehydrogenase (DELTA1-KstDR) for the generation of a catabolic pathway enabling cholesterol degradation in human cells. Coexpression with cholesterol-3-hydroxy-dehydrogenase (CholD) and 3-oxosteroid-9alpha-hydroxylase (Kst-9alphaH). CholD activity catalyzes the generation of a C-3 ketone, which is needed for DELTA1-KstD activity, which introduces a double bond between the C-1 and C-2 atoms of 3-oxosteroids. Cholesterol catabolism pathway in Actinomycetes, overview. The downstream enzymes need to have equal or greater activity when compared to the enzymes acting upstream to allow the pathway to flow and to prevent the accumulation of toxic intermediates, kinetic study 763735
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4more enzyme from strain ST-095 only differs in residue V366 from strain JC-12 (S366). Mutation results in almost 3fold higher catalytic efficiency in strain JC-12 -, 743031
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4more enzyme mutants are constructed based on in silico protein docking modeling using site-directed mutagenesis and exogenous expression -, 763772
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4more targeted disruption of the MSMEG5898 (ksdD-1) gene, but not the MSMEG4855 (ksdD-2) gene, results in partial inactivation of the cholesterol degradation pathway and accumulation of the intermediate 4-androstene-3,17-dione, reversible by the introduction of the wild-type ksdD-1 gene into deltaksdD-1 or overexpression of ksdD-2 -, 675829
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4R256A site-directed mutagenesis, almost inactive mutant -, 763180
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4R256H site-directed mutagenesis, the mutant shows over 70% reduced activity compare to wild-type enzyme 763180
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4R273A site-directed mutagenesis, inactive mutant 763180
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4S138A site-directed mutagenesis, no significant change in enzyme expression is caused by the mutation, the mutant shows reduced activity with 4-androstene-3,17-dione compared to wild-type enzyme -, 763772
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4S325F mutant enzyme has no detectable KSTD enzyme activity -, 656722
Show all pathways known for 1.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.4T503I mutant enzyme has no detectable KSTD enzyme activity -, 656722
<< < Results 11 - 20 of 33 > >>